Authors: Savage, DG Rule, SAJ Tighe, M Garrett, TJ Oster, MW Lee, RT Ruiz, J Heitjan, D Keohan, ML Flamm, M Johnson, SA

Citation: Dg. Savage et al., Gemcitabine for relapsed or resistant lymphoma, ANN ONCOL, 11(5), 2000, pp. 595-597

Authors: Petrylak, DP Macarthur, RB O'Connor, J Shelton, G Judge, T Balog, J Pfaff, C Bagiella, E Heitjan, D Fine, R Zuech, N Sawczuk, I Benson, M Olsson, CA

Citation: Dp. Petrylak et al., Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer, J CL ONCOL, 17(3), 1999, pp. 958-967

Authors: Goluboff, ET Shabsigh, A Saidi, JA Weinstein, IB Mitra, N Heitjan, D Piazza, GA Pamukcu, R Buttyan, R Olsson, CA

Citation: Et. Goluboff et al., Exsulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis, UROLOGY, 53(2), 1999, pp. 440-445

Authors: Longley, BJ Metcalfe, DD Tharp, M Wang, XM Tyrrell, L Lu, SZ Heitjan, D Ma, YS

Citation: Bj. Longley et al., Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis, P NAS US, 96(4), 1999, pp. 1609-1614

Authors: Shabisgh, A Tanji, N D'Agati, V Burchardt, M Rubin, M Goluboff, ET Heitjan, D Kiss, A Buttyan, R

Citation: A. Shabisgh et al., Early effects of castration on the vascular system of the rat ventral prostate gland, ENDOCRINOL, 140(4), 1999, pp. 1920-1926